Late Phase Clinical Trials
Late phase clinical trials are all about a successful transition from development to commercialisation and it is important to understand that they are conducted for various reasons that differ to those of earlier stage clinical trials. In some cases, it will be for providing a strong confirmation of your product’s pre-approval study data on larger patient groups; in other case, it will be for the exploration of new indications by studying different patient populations.
Different goals mean a different approach and we always keep in mind that your clients are our clients too. In this context, we will strive to develop a fruitful relationship with investigators and to promote the image of your company and compounds as if they were our own. We know you worked hard to build and maintain sponsor/site relationships and we will make sure we never compromise them. Our monitors will simply be an extension of your own field staff.
At every stage of the project we will give you the visibility and transparency you need to check the progress of your research without involving you in tedious micromanagement and unnecessary work.
Project Management / Medical Writing / Medical Monitoring
Site Identification and Qualification / Regulatory Affairs
Clinical Monitoring / Data Management and Biostatistics
Pharmacovigilance / Quality Assurance
Call us to find out how our Phase II and III Clinical Trials Solutions can work for you
Health News - Africa
- South Africa: Brakpan Police Station Temporarily Closed for Decontamination Due to COVID-19 Related Incident
- Congo-Kinshasa: 'Mafia Network' At Centre of COVID Fund Fraud in DR Congo, Says Junior Minister
- Malawi: Providing Care for Cervical Cancer in Malawi
- Africa: Refugees in Africa 'Even More Vulnerable Than Ever' Amid COVID Crisis
- Rwanda: Twenty-two New COVID-19 Cases Identified Out of 2,644 Samples
- Rwanda: New Cases, Recoveries as Rwanda Sees COVID-19 Rates Rise
- Africa: WHO Announces Independent Evaluation of Global COVID-19 Response
- Africa: WHO Calls for Equitable Access to Future COVID-19 Vaccines in Africa
- South Africa: Gauteng Health On Six Confirmed COVID-19 Cases in the War Room
- Nigeria: With 460 New Cases, Nigeria's COVID-19 Burden Crosses 30,000 Mark